glycan optimization of human monoclonal antibody in the aquatic plant lemna minor elleke bosma...
Post on 21-Dec-2015
226 views
TRANSCRIPT
![Page 1: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/1.jpg)
Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor
Elleke BosmaHarmen KloosterboerRutger Mantingh
Prof.Dr. Dirk Bosch
![Page 2: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/2.jpg)
Introduction
Xylose 1,3-Fucose
Plant glycosylationHuman Ab
![Page 3: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/3.jpg)
Introduction
- ADCC: Antibody Dependent Cell-mediated Cytotoxicity
-mAbs as therapeutics: effectiveness depends on FcR and for example ADCC
-ADCC and FcR binding dependent on N-glycan structures
![Page 4: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/4.jpg)
Research goals
Designing an optimized plant model for the efficient production of therapeutic mAbs
-Eliminating immunogenic glycans Xylose and Fucose
![Page 5: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/5.jpg)
Results (1a)Lex system (Lemna expression system)
- MDX-060 LEX
-MDX-060 LEXOPT
RNAi against Fucose and Xylosetransferases
![Page 6: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/6.jpg)
Results (1b)
Purifying the Abs : Protein A binds IgG
- Flow Trough: no IgG- Eluate: IgG
SDS-PAGE
![Page 7: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/7.jpg)
Results (2a)MALDI TOF MS analysis
![Page 8: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/8.jpg)
Results (2b)NP-HPLC-QTOF MS analysis
![Page 9: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/9.jpg)
![Page 10: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/10.jpg)
Results (3a)Flow cytometry
FITC sec Ab
![Page 11: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/11.jpg)
Results (3b)Equilibrium binding of Ab to FcR
FcR
![Page 12: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/12.jpg)
Results (3c)ADCC Activity (cell lysis)
(experimental release – spontaneous release) X 100
(maximal release – spontaneous release)
Homozygote Heterozygote
![Page 13: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/13.jpg)
Summary/Conclusion
Fucose and xylose can be succesfully removed by RNAi against their transferases
The produced Abs effectively bind antigens
The produced Abs show increased FcR binding
The produced Abs show increased ADCC activation
The produced Abs show glycosylation homogeneity
![Page 14: Glycan optimization of human monoclonal antibody in the aquatic plant lemna minor Elleke Bosma Harmen Kloosterboer Rutger Mantingh Prof.Dr. Dirk Bosch](https://reader031.vdocuments.us/reader031/viewer/2022020102/56649d5c5503460f94a3b20f/html5/thumbnails/14.jpg)
Discussion/Future
The produced Abs show glycosylation homogeneity ?- Are all Abs glycosylated ?- Is glycan removal 100% effective?
Use whole Abs as control in MS analysis
Abs purification on a large scale?- No secretion by plant cells.